Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Apr 19, 2022	SC TO-C	Written public communication relating to an issuer or third party tender offer	View HTML 0001104659-22-047376.pdf 0001104659-22-047376.xls
Apr 11, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-22-000038.pdf 0001708138-22-000038.xls
Apr 11, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-22-000039.pdf 0001708138-22-000039.xls
Apr 11, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-22-000040.pdf 0001708138-22-000040.xls
Apr 11, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000040.pdf 0001883850-22-000040.xls
Apr 07, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000038.pdf 0001883850-22-000038.xls
Apr 04, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000035.pdf 0001883850-22-000035.xls
Apr 04, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000036.pdf 0001883850-22-000036.xls
Apr 04, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-22-000033.pdf 0001708138-22-000033.xls
Apr 04, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-22-000034.pdf 0001708138-22-000034.xls

Data provided by Kaleidoscope.

Investors & Media